• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于全球疫苗数据的新冠疫苗对每日病例及死亡的影响

The Effect of the COVID-19 Vaccine on Daily Cases and Deaths Based on Global Vaccine Data.

作者信息

Li Zhiwei, Liu Xiangtong, Liu Mengyang, Wu Zhiyuan, Liu Yue, Li Weiming, Liu Mengmeng, Wang Xiaonan, Gao Bo, Luo Yanxia, Li Xia, Tao Lixin, Wang Wei, Guo Xiuhua

机构信息

Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, 10 Xi-Tou-Tiao, You-An-Men Street, Fengtai District, Beijing 100069, China.

Beijing Municipal Key Laboratory of Clinical Epidemiology, Capital Medical University, Beijing 100071, China.

出版信息

Vaccines (Basel). 2021 Nov 15;9(11):1328. doi: 10.3390/vaccines9111328.

DOI:10.3390/vaccines9111328
PMID:34835259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8622191/
Abstract

BACKGROUND

Coronavirus disease 2019 (COVID-19), a global pandemic, has caused over 216 million cases and 4.50 million deaths as of 30 August 2021. Vaccines can be regarded as one of the most powerful weapons to eliminate the pandemic, but the impact of vaccines on daily COVID-19 cases and deaths by country is unclear. This study aimed to investigate the correlation between vaccines and daily newly confirmed cases and deaths of COVID-19 in each country worldwide.

METHODS

Daily data on firstly vaccinated people, fully vaccinated people, new cases and new deaths of COVID-19 were collected from 187 countries. First, we used a generalized additive model (GAM) to analyze the association between daily vaccinated people and daily new cases and deaths of COVID-19. Second, a random effects meta-analysis was conducted to calculate the global pooled results.

RESULTS

In total, 187 countries and regions were included in the study. During the study period, 1,011,918,763 doses of vaccine were administered, 540,623,907 people received at least one dose of vaccine, and 230,501,824 people received two doses. For the relationship between vaccination and daily increasing cases of COVID-19, the results showed that daily increasing cases of COVID-19 would be reduced by 24.43% [95% CI: 18.89, 29.59] and 7.50% [95% CI: 6.18, 8.80] with 10,000 fully vaccinated people per day and at least one dose of vaccine, respectively. Daily increasing deaths of COVID-19 would be reduced by 13.32% [95% CI: 3.81, 21.89] and 2.02% [95% CI: 0.18, 4.16] with 10,000 fully vaccinated people per day and at least one dose of vaccine, respectively.

CONCLUSIONS

These findings showed that vaccination can effectively reduce the new cases and deaths of COVID-19, but vaccines are not distributed fairly worldwide. There is an urgent need to accelerate the speed of vaccination and promote its fair distribution across countries.

摘要

背景

2019年冠状病毒病(COVID-19)是一场全球大流行疾病,截至2021年8月30日,已导致超过2.16亿例感染和450万人死亡。疫苗可被视为消除该大流行的最有力武器之一,但疫苗对各国每日COVID-19病例和死亡的影响尚不清楚。本研究旨在调查全球各国疫苗接种与每日新增COVID-19确诊病例和死亡之间的相关性。

方法

收集了187个国家关于首次接种疫苗者、完全接种疫苗者、COVID-19新增病例和新增死亡的每日数据。首先,我们使用广义相加模型(GAM)分析每日接种疫苗者与每日COVID-19新增病例和死亡之间的关联。其次,进行随机效应荟萃分析以计算全球汇总结果。

结果

本研究共纳入187个国家和地区。在研究期间,共接种了1011918763剂疫苗,540623907人至少接种了一剂疫苗,230501824人接种了两剂疫苗。对于疫苗接种与每日COVID-19新增病例之间的关系,结果显示,每天每有10000名完全接种疫苗者和至少接种一剂疫苗者,COVID-19每日新增病例数将分别减少24.43%[95%置信区间:18.89,29.59]和7.50%[95%置信区间:6.18,8.80]。每天每有10000名完全接种疫苗者和至少接种一剂疫苗者,COVID-19每日新增死亡数将分别减少13.32%[95%置信区间:3.81,21.89]和2.02%[95%置信区间:0.18,4.16]。

结论

这些研究结果表明,接种疫苗可有效减少COVID-19的新增病例和死亡,但疫苗在全球范围内的分配并不公平。迫切需要加快疫苗接种速度,并促进其在各国的公平分配。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8338/8622191/813ee86cbdbd/vaccines-09-01328-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8338/8622191/6520c54e7eb8/vaccines-09-01328-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8338/8622191/86f23d3704e1/vaccines-09-01328-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8338/8622191/5ac41be57fdb/vaccines-09-01328-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8338/8622191/813ee86cbdbd/vaccines-09-01328-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8338/8622191/6520c54e7eb8/vaccines-09-01328-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8338/8622191/86f23d3704e1/vaccines-09-01328-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8338/8622191/5ac41be57fdb/vaccines-09-01328-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8338/8622191/813ee86cbdbd/vaccines-09-01328-g004.jpg

相似文献

1
The Effect of the COVID-19 Vaccine on Daily Cases and Deaths Based on Global Vaccine Data.基于全球疫苗数据的新冠疫苗对每日病例及死亡的影响
Vaccines (Basel). 2021 Nov 15;9(11):1328. doi: 10.3390/vaccines9111328.
2
Disparities and effectiveness of COVID-19 vaccine policies in three representative European countries.三个代表性欧洲国家的 COVID-19 疫苗政策的差异和效果。
Int J Equity Health. 2024 Jan 30;23(1):16. doi: 10.1186/s12939-024-02110-w.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
COVID-19 Statistics in the Arab World by the End of October 2022: A Cross-Sectional Study.2022年10月底阿拉伯世界的新冠疫情统计:一项横断面研究。
Cureus. 2022 Dec 18;14(12):e32670. doi: 10.7759/cureus.32670. eCollection 2022 Dec.
5
Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries.人轮状病毒疫苗(HRV)和肺炎球菌多糖蛋白 D 结合疫苗(PHiD-CV)估计对免疫规划支持国家儿童发病率和死亡率的公共卫生影响。
Hum Vaccin Immunother. 2022 Dec 30;18(7):2135916. doi: 10.1080/21645515.2022.2135916. Epub 2022 Dec 12.
6
Vaccine coverage and effectiveness against laboratory-confirmed symptomatic and severe Covid-19 in indigenous people in Brazil: a cohort study.巴西原住民中经实验室确诊的有症状和重症 COVID-19 的疫苗接种率和有效性:一项队列研究。
BMC Public Health. 2023 Jun 29;23(1):1267. doi: 10.1186/s12889-023-16196-4.
7
Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex.COVID-19 疫苗序贯接种与 SARS-CoV-2 感染后心肌炎发病风险:按年龄和性别分层。
Circulation. 2022 Sep 6;146(10):743-754. doi: 10.1161/CIRCULATIONAHA.122.059970. Epub 2022 Aug 22.
8
Association between Gross National Income per capita and COVID-19 vaccination coverage: a global ecological study.人均国民总收入与 COVID-19 疫苗接种覆盖率之间的关系:一项全球生态学研究。
BMC Public Health. 2023 Dec 4;23(1):2415. doi: 10.1186/s12889-023-17241-y.
9
Global impact of the first year of COVID-19 vaccination: a mathematical modelling study.全球首例 COVID-19 疫苗接种一年的影响:一项数学建模研究。
Lancet Infect Dis. 2022 Sep;22(9):1293-1302. doi: 10.1016/S1473-3099(22)00320-6. Epub 2022 Jun 23.
10
The Prevalence of COVID-19 in Europe by the End of November 2022: A Cross-Sectional Study.截至2022年11月底欧洲新冠病毒病的患病率:一项横断面研究
Cureus. 2023 Jan 9;15(1):e33546. doi: 10.7759/cureus.33546. eCollection 2023 Jan.

引用本文的文献

1
Impact of vaccination status on clinical outcomes of hospitalized COVID-19 patients.疫苗接种状况对住院 COVID-19 患者临床结局的影响。
BMC Infect Dis. 2024 Feb 23;24(1):254. doi: 10.1186/s12879-024-09139-w.
2
COVID-19 transmission dynamics and the impact of vaccination: modelling, analysis and simulations.新型冠状病毒肺炎传播动力学及疫苗接种的影响:建模、分析与模拟
R Soc Open Sci. 2023 Jul 26;10(7):221656. doi: 10.1098/rsos.221656. eCollection 2023 Jul.
3
A Meta-Analysis on the Association between Peptic Ulcer Disease and COVID-19 Severity.

本文引用的文献

1
After the pandemic: perspectives on the future trajectory of COVID-19.大流行之后:对 COVID-19 未来轨迹的展望。
Nature. 2021 Aug;596(7873):495-504. doi: 10.1038/s41586-021-03792-w. Epub 2021 Jul 8.
2
Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice.异源疫苗接种方案,使用自我扩增 RNA 和腺病毒 COVID 疫苗,可在小鼠中诱导强烈的免疫反应。
Nat Commun. 2021 May 17;12(1):2893. doi: 10.1038/s41467-021-23173-1.
3
A global database of COVID-19 vaccinations.一个全球 COVID-19 疫苗接种数据库。
消化性溃疡疾病与新型冠状病毒肺炎严重程度关联的Meta分析
Vaccines (Basel). 2023 Jun 11;11(6):1087. doi: 10.3390/vaccines11061087.
4
Barriers and Facilitators Affecting the Uptake of COVID-19 Vaccines: A Qualitative Perspective of Frontline Nurses in Namibia.影响新冠疫苗接种的障碍与促进因素:纳米比亚一线护士的定性视角
SAGE Open Nurs. 2023 Feb 23;9:23779608231158419. doi: 10.1177/23779608231158419. eCollection 2023 Jan-Dec.
5
Spatial and Temporal Analysis of COVID-19 Cases in West Java, Indonesia and Its Influencing Factors.印度尼西亚西爪哇省 COVID-19 病例的时空分析及其影响因素。
Int J Environ Res Public Health. 2023 Feb 11;20(4):3198. doi: 10.3390/ijerph20043198.
6
Parental perceptions and the 5C psychological antecedents of COVID-19 vaccination during the first month of omicron variant surge: A large-scale cross-sectional survey in Saudi Arabia.奥密克戎毒株激增首月期间父母对新冠疫苗接种的认知及5C心理影响因素:沙特阿拉伯的一项大规模横断面调查
Front Pediatr. 2022 Aug 16;10:944165. doi: 10.3389/fped.2022.944165. eCollection 2022.
7
Contrasting Epidemiology and Population Genetics of COVID-19 Infections Defined by Multilocus Genotypes in SARS-CoV-2 Genomes Sampled Globally.从全球采集的 SARS-CoV-2 基因组中的多位点基因型定义的 COVID-19 感染的对比流行病学和群体遗传学。
Viruses. 2022 Jun 29;14(7):1434. doi: 10.3390/v14071434.
Nat Hum Behav. 2021 Jul;5(7):947-953. doi: 10.1038/s41562-021-01122-8. Epub 2021 May 10.
4
An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫苗的最新综述及大流行时期有效疫苗接种计划的重要性
Vaccines (Basel). 2021 Apr 27;9(5):433. doi: 10.3390/vaccines9050433.
5
Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective.COVID-19 疫苗 III 期临床试验及之后的目标产品概况分析:2021 年初展望。
Viruses. 2021 Mar 5;13(3):418. doi: 10.3390/v13030418.
6
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes.SARS-CoV-2 疫苗接种方案的流行病学和进化考虑。
Science. 2021 Apr 23;372(6540):363-370. doi: 10.1126/science.abg8663. Epub 2021 Mar 9.
7
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.基于 rAd26 和 rAd5 载体的异源初免-加强型 COVID-19 疫苗的安全性和有效性:俄罗斯一项随机对照 3 期临床试验的中期分析。
Lancet. 2021 Feb 20;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8. Epub 2021 Feb 2.
8
COVID-19 vaccine: where are we now and where should we go?COVID-19 疫苗:我们现在在哪里,我们应该往哪里走?
Expert Rev Vaccines. 2021 Jan;20(1):23-44. doi: 10.1080/14760584.2021.1875824. Epub 2021 Feb 17.
9
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.新冠病毒治疗和诊断方法的最新进展。
AAPS J. 2021 Jan 5;23(1):14. doi: 10.1208/s12248-020-00532-2.
10
[Epidemiology and public health in the COVID-19 epidemic].[新型冠状病毒肺炎疫情中的流行病学与公共卫生]
Medicine (Madr). 2020 Dec;13(23):1297-1304. doi: 10.1016/j.med.2020.12.011. Epub 2020 Dec 24.